As we move into the final quarter of another roller coaster year, the HealthTech Activator (HTA) is excited to announce several new, upcoming events across reimbursement, regulatory, and market validation topics.
Check out more info and links to the events, along with other news and resources, below!
We’d also love to hear about your needs: please complete this short survey (thank you to those who completed it last month) to tell us more about how we can help to build further resources for our community (approximately 3 mins).
This interactive tutorial, facilitated by Tara Creaven-Capasso of Caduceus Medical Development, will give you tools and resources to make keeping up with regulatory changes and standards easier and more efficient.
Read more and register here.
Join us for a US medical device reimbursement interactive tutorial with health economics and reimbursement specialist Jay Stracke. This will also include a discussion about the challenges for Software as a Medical Device (SaMD) products and will close with a Q&A.
16-17 November, Auckland
We’re pleased to announce the HTA's newly developed in-person market validation workshops, the first of these will be: Putting customers at the heart of healthtech - clarifying who your customer is and developing your market entry approach.
The workshop is aimed at early stage healthtech companies, or companies that would like to have a fresh look at their customers, market and how they have validated it to date.
The Quality Management System Primer is a wholly online, self-paced course providing an overview of quality management systems, their benefits and what you need to consider before implementation. It is provided by SeerPharma and there is no cost to you for this programme.
Although the focus for healthtech companies is often on the clinical or economic data required to support claims and regulatory compliance, more foundational data about customer-value is also required to validate a target market. It’s also key to securing investment and partnerships. This month’s blog discusses market research and how the HTA can help.
High-tech 'cocoons' at Malaghan Institute aim to speed up cancer therapy trials
Volpara signs second lung screening partnership (NBR-Paid)
New Zealand startup HeartLab raises $2.45M to bring heart scanning software to the US
Gene therapy receives US FDA approval for in-human clinical trial